1. Antiviral drugs for treatment and prophylaxis of seasonal influenza,2019
2. Cost-effectiveness of dasatinib versus nilotinib for the secondline treatment of patients with chronic myeloid leukemia (CML) under the brazilian private healthcare system;Araujo;JBES Braz. J. Health Econ. J. Bras. Econ. Saúde,2014
3. Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: a practical guide;Bilcke;Med. Decis. Making,2011
4. Departamento de Vigilância das Doenças Transmissíveis,2017
5. Portaria N° 2.436, de 21 de setembro de 2017,2017